These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7030898)

  • 1. Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes.
    Gray RS; Borsey DQ; Kurtz A; Rainbow S; Smith AF; Elton RA; Duncan LJ; Clarke BF
    Horm Metab Res; 1981 Nov; 13(11):599-603. PubMed ID: 7030898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylated haemoglobin and serum insulin antibodies in type I diabetes.
    Gray RS; Borsey DQ; Duncan LJ; Clarke BF; Smith BF; Kurtz AB; Rainbow S; Elton RA
    Scott Med J; 1984 Jul; 29(3):150-3. PubMed ID: 6398512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary C-peptide as an index of unstable glycemic control in insulin-dependent diabetes mellitus (IDDM).
    Cha T; Tahara Y; Ikegami H; Fukuda M; Yoneda H; Yamato E; Yamamoto Y; Noma Y; Shima K; Ogihara T
    Diabetes Res Clin Pract; 1991 Sep; 13(3):181-7. PubMed ID: 1959481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
    Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ
    Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
    Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
    Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet-cell antibodies: markers of a more severe insulin-dependent diabetes mellitus?
    Montaña E; Goday A; Rosel P; Casamitjana R; Soler J; Gomis R
    Diabetes Res; 1989 Aug; 11(4):167-71. PubMed ID: 2625032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin antibody response to bovine insulin therapy: functional significance among insulin requiring young diabetics in India.
    Goswami R; Jaleel A; Kochupillai NP
    Diabetes Res Clin Pract; 2000 Jul; 49(1):7-15. PubMed ID: 10808058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in blunted glucagon response to insulin-induced hypoglycemia by strict glycemic control in diabetics.
    Katsura M; Kawamori R; Yamasaki Y; Iwama N; Kubota M; Goriya Y; Kajimoto Y; Shichiri M; Kamada T
    Diabetes Res Clin Pract; 1993 May; 20(2):93-100. PubMed ID: 8375272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve.
    Clarson C; Daneman D; Drash AL; Becker DJ; Ehrlich RM
    Diabetes Care; 1987; 10(1):33-8. PubMed ID: 3552512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.
    Keymeulen B; Ling Z; Gorus FK; Delvaux G; Bouwens L; Grupping A; Hendrieckx C; Pipeleers-Marichal M; Van Schravendijk C; Salmela K; Pipeleers DG
    Diabetologia; 1998 Apr; 41(4):452-9. PubMed ID: 9562350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies.
    Snorgaard O; Kjems LL; Røder ME; Hartling SG; Dinesen B; Binder C
    Diabetes Care; 1996 Feb; 19(2):146-50. PubMed ID: 8718435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
    Hinds A; Sheehan AG; Machida H; Parsons HG
    Diabetes Res; 1991 Oct; 18(2):69-78. PubMed ID: 1841815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control.
    Sjöberg S; Gunnarsson R; Ostman J
    Acta Med Scand; 1983; 214(3):231-7. PubMed ID: 6362338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
    Elamin A; Omer MI; Tuvemo T
    Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, pancreatic polypeptide, and glucagon antibodies in insulin-dependent diabetes mellitus.
    Asplin CM; Hollander P; Pecoraro RE; Brodsky J; Palmer JP
    Diabetes Care; 1981; 4(3):337-42. PubMed ID: 7047110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.